Tag : dissemination

Dermatology

Non-canonical EphA2 signaling is a driver of tumor-endothelial cell interactions and metastatic dissemination in BRAF inhibitor resistant melanoma

Newsemia
Acquired BRAF/MEK inhibitor resistance in melanoma results in a new transcriptional state associated with increased risk of metastasis. Here, we identified non-canonical EphA2 signaling as...
Neurology

Practice advisory: Thymectomy for myasthenia gravis (practice parameter update): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Newsemia
Objective To review updated evidence regarding the effectiveness of thymectomy for treating patients with myasthenia gravis (MG). Methods The practice advisory panel performed a systematic...
Neurology

Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Newsemia
Objective To review pharmacologic and nonpharmacologic strategies for treating sleep disturbances in children and adolescents with autism spectrum disorder (ASD) and to develop recommendations for...
Neurology

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

Newsemia
Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology...
Neurology

Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

Newsemia
In the Special Article “Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee...
Latest News

Enhancing scientific dissemination in neuroscience via preprint peer-review: “Peer Community In Circuit Neuroscience”

Newsemia
Mercier, M; Magloire, V; Karnani, M; (2020) Enhancing scientific dissemination in neuroscience via preprint peer-review: “Peer Community In Circuit Neuroscience”. Neuroanatomy and Behaviour , 2...
Neurology

Editors' note: Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Newsemia
In the special article “Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis,” Rae-Grant et al. reported the findings of the Guideline Development, Dissemination,...
Neurology

Reader response: Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Newsemia
Genentech recognizes that high-quality and trustworthy guidelines, such as those published by the American Academy of Neurology, are important both for providers to optimize patient...
Neurology

Author response: Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Newsemia
I thank Dr. Tran for the comment on our comprehensive systematic review summary for the American Academy of Neurology guideline on disease-modifying therapy for adults...
Neurology

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Newsemia
Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of...
Neurology

Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Newsemia
Objective To update the 2002 American Academy of Neurology (AAN) guideline regarding immunization and multiple sclerosis (MS). Methods The panel performed a systematic review and...
Neurology

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

Newsemia
Objective To provide updated evidence-based recommendations for migraine prevention using pharmacologic treatment with or without cognitive behavioral therapy in the pediatric population. Methods The authors...
Neurology

Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

Newsemia
Objective To provide evidence-based recommendations for the acute symptomatic treatment of children and adolescents with migraine. Methods We performed a systematic review of the literature...
Neurology

Reader response: Evidence in focus: Nusinersen use in spinal muscular atrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Newsemia
Nusinersen is effective for patients with spinal muscular atrophy (SMA) and has been approved in the United States, Europe, and Japan.1 No life-threatening adverse events...
Neurology

Editors' note: Evidence in focus: Nusinersen use in spinal muscular atrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Newsemia
In the article “Evidence in focus: Nusinersen use in spinal muscular atrophy,” Michelson et al. systematically reviewed 4 published clinical trials of nusinersen for patients...
Neurology

Practice guideline update recommendations summary: Disorders of consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research

Newsemia
In this issue of Neurology, Dr. Salas and a team of sleep medicine and medical education experts representing 6 major academic centers report on the...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World